We bring you exclusive sessions from our scientific workshops, featuring roundtable discussions with world-leading experts.
Each session focuses on a key topic aligned with the workshop program.
On-demand Sessions
Explore roundtable discussions from our scientific workshops
Novel targets, combinations & treatments in AML: use of OGM, TP53 treatment strategies & ADCs
iwAL 202413 - 15 September, 2024
Updates on established therapies in AML – Part 2
iwAL 202413 - 15 September, 2024
Updates on established therapies in AML – Part 1
iwAL 202413 - 15 September, 2024
Novel treatments & combinations in AML: mechanisms of resistance to venetoclax & approaching R/R disease
iwAL 202413 - 15 September, 2024
The treatment landscape and challenges in rare diseases: BPDCN, CMML, MPN-AP/BP, and VEXAS
iwAL 202413 - 15 September, 2024
Current data on menin inhibition in AML
iwAL 202413 - 15 September, 2024
Updates in the diagnosis, classification & risk stratification of MDS
iwMDS 202428 - 30 June, 2024
Inflammation & immune interventions in MDS: targeting STAT, IRAK4 & more
iwMDS 202428 - 30 June, 2024
Updates in HR-MDS therapies: IDH inhibitors, challenges with transplantation, and more
iwMDS 202428 - 30 June, 2024
Allo approaches in CAR-T
iwCAR-T 202419 - 21 April, 2024
The future of CAR-T therapy in AML
iwCAR-T 202419 - 21 April, 2024
CAR T-cells for autoimmune diseases
iwCAR-T 202419 - 21 April, 2024
An update on CAR-T in CLL
iwCAR-T 202419 - 21 April, 2024
Understanding mechanisms of resistance to targeted therapies in myeloma
iwMyeloma 202412 - 14 April, 2024
Early Interception In SMM & Novel Agents Being Explored
IBC Workshop 202414 - 16 March, 2024
Updates On The Biology And Treatment Of T-Cell Lymphoma
iwNHL 202329 September - 1 October, 2023
Clonal Hematopoiesis, Early Detection & Potential Therapeutics
iwAL 202325 - 27 August, 2023
CAR-T in AML: updates & challenges
iwCAR-T 202314 - 16 April, 2023
How can we improve efficiency of drug approval for MDS?
iwMDS 202224 - 26 June, 2022
Contact Us
If you would like more information, or are interested in supporting one of our on-demand sessions
